UroToday.com - The use of PSA screening for the detection and treatment of prostate cancer (CaP) has been controversial. Two articles on this topic appear in the March 18, 2009 online edition of the New England Journal of Medicine. This article by Dr. Gerald Andriole and associates and the other by Professor Fritz Schöder […]
Filed under: Clinical Trials on April 26th, 2009 | No Comments »
A combination of sorafenib and vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Center at Jefferson. Data from the two studies were presented at the AACR 100th Annual Meeting 2009 in Denver.
More: continued here
Filed under: Liver Disease / Hepatitis on April 26th, 2009 | No Comments »
California lawmakers are considering legislation (AB 119) that would prohibit insurers from taking a health insurance applicant’s sex into account when setting premiums, a practice known as gender rating, the San Jose Mercury News reports.
More: continued here
Filed under: Health Insurance / Medical Insurance on April 26th, 2009 | No Comments »
The Washington state House on Monday voted 89-9 to approve a bill (HB 2341) that would eliminate beneficiaries from the state’s Basic Health Plan if they receive separate health benefits from the state Department of Social and Health Services, the
More: continued here
Filed under: Health Insurance / Medical Insurance on April 26th, 2009 | No Comments »
Maine Standards Company, LLC recently received clearance from the U.S. Food and Drug Administration (FDA) for the VALIDATE® CM2 test set. The VALIDATE® CM2 test set includes BNP / nt-proBNP, hsCRP and Troponin for easier calibration verification / linearity testing. This clearance will allow clinical laboratories to more easily complete their required cardiac marker linearity […]
Filed under: Cardiovascular on April 26th, 2009 | No Comments »
Without preventative treatment, 45,000 people undergoing elective hip or knee replacement every year in England could develop a potentially fatal blood clot. NICE now recommends Xarelto - a new, oral anticoagulant, up to 70% more effective at reducing blood clots than the current gold standard (injectable enoxaparin).
More: continued here
Filed under: Blood on April 26th, 2009 | No Comments »
A shocking 90% of calls to Arthritis Care’s helpline in the last 12 months have been cries for help over pain - so this year, the charity is marking its awareness week by urging doctors, nurses and allied health professionals to support people with arthritis in making a special challenge to pain and the constraints […]
Filed under: Arthritis on April 26th, 2009 | No Comments »
Most parents who have lost a premature baby still hold the baby in a central place in their lives two to six years after the baby’s death, physicians report in a new small study. According to lead author Stefan Büchi, M.D., how they share this grief and suffering depends on the emotional exchange and communication […]
Filed under: Anxiety on April 26th, 2009 | No Comments »
Laboratory and epidemiological studies continue to show that sleep curtailment and/or decreased sleep quality can disturb neuroendocrine control of appetite, leading to overeating, and can decrease insulin and/or increase insulin resistance, both steps on the road to Type 2 diabetes. On April 22, at the Experimental Biology 2009 meeting in […]
Filed under: Diabetes on April 26th, 2009 | No Comments »
Drinking at least one glass of low sodium vegetable juice daily may help overweight people with metabolic syndrome achieve better weight loss results. A study, conducted at the Baylor College of Medicine and presented at this week’s Experimental Biology Meeting, found that participants who drank at least 8-ounces of low sodium vegetable juice as part […]
Filed under: Hypertension on April 26th, 2009 | No Comments »